| FDA: MS Drug Effective, But Has 'Safety Issues' The FDA said a proposed Novartis drug that would treat multiple sclerosis was effective but carried "a number of safety issues." online.wsj.com |
Arena Pharmaceuticals: The Next Multi-Billion Dollar Biotech? John Tucker submits: Long-suffering Arena Pharmaceutical (ARNA) shareholders are basking in the warm glow of vindication this week. After years of disappointing performance, the company’s share value has more than doubled since June 30. With its lead product candidate Lorcaserin widely dismissed as the least effective of the three obesity drugs currently in late stage development, Arena’s share price actually dropped the day it announced the results of its first successful phase 3 clinical trial. With the events of the last few weeks, Arena’s market capitalization now exceeds that of its competitors by a wide margin (Table 1), and the recent share price trajectory suggests that Arena could become a billion dollar company well in advance of an FDA decision on Lorcaserin. click to enlargeComplete Story » seekingalpha.com |
Stem-Cell Ruling Puts Labs in Limbo Experiments using human embryonic stem cells are in a state of limbo across the country, following a judge's injunction on Monday to block any such research funded by the federal government. online.wsj.com |
Tylenol 8-Hour Caplets Recalled on Musty Odor A Johnson & Johnson unit said it is recalling more than 100,000 bottles of Tylenol 8-Hour caplets after a small number of complaints about a musty or moldy odor. online.wsj.com |
Clean Sweep Tips for Nasal Allergy Sufferers - Video New Campaign Provides Nasal Allergy Sufferers "Clean Sweep" Tips for Spring Allergy Season feedproxy.google.com |